Acute Porphyria Drug Database

Monograph

N05CD05 - Triazolam
Propably not porphyrinogenic
PNP

Rationale
Metabolised by CYP 3A4, but no CYP- inducing effects observed. Therapeutic serum concentrations probably below micromolar range.
Chemical description
Benzodiazepine with a triazol ring added. Shortacting, used as hypnotic. Metabolized by CYP 3A4. Does not give rise to induction of human CYPs. Porphyrinogenic in chick embryo liver cells. MFM James, RJ Hift. Porphyrias. Br J Anaesth 2000; 85, 143-53: use. Australian list: safe South African list: use French list: avoid, known to have precipitated an acute attack Thunell, patient inquiry: tolerated (n=2) Kauppinen and Mustajoki. Prognosis of acute porphyria... Medicine 1992; 71: 1-13: tolerated (N=1).
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes N05C / N05CD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Belgium
Halcion · Halcion 0.125 mg comp. · Halcion 0.25 mg comp.
Denmark
Halcion
Norway
Halcion · Halcion 2care4
Luxembourg
HALCION
Finland
Halcion
Latvia
Halcion
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙